Hyperlipidemia

The detailed results of an analysis of 53 patients hospitalized with severe complications of COVID-19 who were treated with the...


Results from a prespecified analysis of pooled data from three phase III studies evaluating the safety and efficacy of Inclisiran,...


Objective of the study was to disentangle the role of nonsteroidal anti-inflammatory drugs ( NSAIDs ) in the increased risk...


The FDA ( U.S. Food and Drug Administration ) has approved Praluent ( Alirocumab ) to reduce the risk of...


Although there are many different antiarrhythmic drugs approved for rhythm management of atrial fibrillation, little comparative effectiveness data exist to...


The Phase 3 SPIRE-AI ( AutoInjector ) trial of the investigational Proprotein Convertase Subtilisin Kexin type 9 inhibitor ( PCSK9i...


A reduction of cardiovascular events has been reported in phase 2 and 3 trials of the proprotein convertase subtilisin kexin...


New detailed data from the phase 3 YUKAWA-2 study evaluating Evolocumab ( Repatha ), a novel investigational cholesterol-lowering medication, in...


Merck, known as MSD outside the United States and Canada, issued the following statement after the conclusion of a meeting...


The European Medicines Agency ( EMA ) has recommended granting a marketing authorisation for Kanuma ( Sebelipase alfa ), for...


It is known that the risk of stroke in patients with traumatic brain injury might be increased. However, the relationship...


In February 2014, the American Heart Association [ AHA ] /American Stroke Association [ ASA ] released their first guideline...


Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 ( PCSK9 ). PCSK9 is a...


The extracranial venous system is complex and variable between individuals. Until recently, these variations were acknowledged as developmental variants and...


Excess weight and obesity in the general population are increasing problems throughout the Western world, and this rise has also...


Raptiva ( Efalizumab ) is an immunosuppressive, humanized monoclonal antibody indicated for treatment of adult patients with moderate to severe...


Raptiva ( Efalizumab ) is an immunosuppressive, humanized monoclonal antibody indicated for treatment of adult patients with moderate to severe...


The FDA ( Food and Drug Administration ) has approved Zortress ( Everolimus ) oral tablets for the prevention of...


Women with a history of hypothyroidism face a significantly higher risk of developing liver cancer.Hypothyroidism is the most common thyroid...


The thiazolidinedione Rosiglitazone ( Avandia ) is an insulin sensitizer that is indicated for use either as monotherapy or in...